US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

TCRX TScan Therapeutics Inc

8.55

0.26 (3.14%)

31 May 2024 - Cerrado

Retrasado por 15 minutos

Form 3 - Initial statement of beneficial ownership of securities

TScan Therapeutics (NASDAQ:TCRX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Haga Click aquí para más Gráficas TScan Therapeutics.

TScan Therapeutics (NASDAQ:TCRX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024

Haga Click aquí para más Gráficas TScan Therapeutics.

Noticias sobre TScan Therapeutics Inc TCRX

TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare Conference
Jueves 30 de Mayo 2024 (3 días hace) • GlobeNewswire Inc.

TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme Malignancies
Miércoles 29 de Mayo 2024 (4 días hace) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Lunes 13 de Mayo 2024 (3 semanas hace) • Edgar (US Regulatory)

Form 8-K - Current report
Lunes 13 de Mayo 2024 (3 semanas hace) • Edgar (US Regulatory)

TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Lunes 13 de Mayo 2024 (3 semanas hace) • GlobeNewswire Inc.

TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors
Jueves 9 de Mayo 2024 (3 semanas hace) • GlobeNewswire Inc.

TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting
Miércoles 24 de Abril 2024 (1 mes hace) • GlobeNewswire Inc.

TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares
Miércoles 24 de Abril 2024 (1 mes hace) • GlobeNewswire Inc.

TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
Lunes 22 de Abril 2024 (1 mes hace) • GlobeNewswire Inc.

TScan Therapeutics Announces Closing of Upsized Public Offering
Viernes 19 de Abril 2024 (1 mes hace) • GlobeNewswire Inc.

TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering
Martes 16 de Abril 2024 (2 meses hace) • GlobeNewswire Inc.

TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering
Martes 16 de Abril 2024 (2 meses hace) • GlobeNewswire Inc.

Más de TScan Therapeutics Inc Artículos de Noticias

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones